Skip to main content
 

Events

The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).

Friday, July 28, 2017, 12:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

Please join us for a special CCR Grand Rounds, the 2017 AAAS Martin and Rose Wachtel Cancer Research Award Lecture, “Charting the Unknown Unknowns of Cancer Progression,” by Hani Goodarzi, Ph.D., Assistant Professor in the Department of Biophysics & Biochemistry at UCSF.  

Cancer, fundamentally, is a disease of disordered gene expression. Cancer cells rely on deregulated expression of oncogenic and tumor suppressive pathways to initiate and maintain the transformation process. Thus, delineating how cancer cells achieve such pathologic gene expression states is a crucial step towards understanding and ultimately treating cancer as a disease. Towards achieving this goal, Goodarzi’s laboratory employs a systems biological and multidisciplinary approach that integrates computational and experimental strategies to identify and characterize key regulatory programs that underlie cancer progression. The systems-level frameworks implemented in our lab ensure a truly unbiased and systematic approach to studying this key biological challenge. Such bottom-up and agnostic approaches are crucial for discovering pathways that fall outside of our prior knowledge of regulatory interactions and would otherwise remain hidden in a top-down reductionist framework. The lab’s goal is to develop novel strategies for studying, diagnosing, and ultimately treating cancer.

Thursday, August 3, 2017, 2:00 pm to 3:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

William Gahl, M.D., Ph.D., clinical director of the National Human Genome Research Institute (NHGRI) and the Undiagnosed Diseases Program, will present a summer lecture titled “The NIH Undiagnosed Diseases Program and Network: Diagnosis and Discovery” as part of the 2016-2017 DIR Genome Seminar Series. This seminar is free and open to the public.

The immensely successful and NIH-intramural initiated Undiagnosed Diseases Program (UDP) is now part of the Undiagnosed Disease Network (UDN), an NIH Common Fund initiative that focuses on the most puzzling medical cases referred to the NIH Clinical Center. It was organized by NHGRI, the NIH Office of Rare Diseases Research (ORDR) and the NIH Clinical Center. Many medical specialties from other NIH research centers and institutes contribute the expertise needed to conduct the program, including endocrinology, immunology, oncology, dermatology, dentistry, cardiology and genetics, among the dozens of participating senior attending physicians. Its purpose is to bring together clinical and research experts from across the United States to solve the most challenging medical mysteries using advanced technologies. 

Monday, August 7, 2017, 12:00 pm to Tuesday, August 8, 2017, 3:15 pm

Ruth Kirschstein Auditorium, Natcher Building (Bldg. 45)

The National Institute of Nursing Research presents a summit, “The Science of Caregiving: Bringing Voices Together”. NINR and its partners invite you to this summit to provide perspectives across the spectrum of caregiving, including the importance of caregiving across the lifespan as well as current and future directions for research to improve the health of patients and caregivers. The keynote speaker is Judy Woodruff of PBS NewsHour. In addition, the Directors of Ceremonies for the event are Gail Hunt of the National Alliance for Caregiving on August 7 and Dr. Laura Gitlin of the Center for Innovative Care in Aging at the Johns Hopkins University School of Nursing on August 8.  The event will bring together an audience of researchers, advocates, healthcare providers, educators, and others interested in the science of caregiving.

This event is free but space is limited and registration is required. NINR’s partners for this event include the National Cancer Institute, the National Institute on Aging, the Eunice Kennedy Shiver National Institute of Child Health and Human Development, the National Institute on Minority Health and Health Disparities, the National Center for Advancing Translational Sciences’ Office of Rare Diseases Research, the NIH Office of Behavioral and Social Sciences Research, the NIHOffice of Disease Prevention, and the NIH Office of Research on Women's Health.

Thursday, August 10, 2017, 9:00 am to 3:00 pm

Natcher Conference Center (Bldg. 45)

Join  us for Summer Poster Day 2017. This is the interns’ time to share the research they have been conducting at the NIH while developing communication and networking skills.  Any student (high school, college, medical/dental, or graduate) working in an intramural research group this summer may present. You may not have final results. However, you can still present background information on your project, any data you may have collected, or a discussion of the technical problems you encountered. We encourage all current summer interns in Bethesda/Rockville, Baltimore, and Frederick to present at this event.  During the session, you will spend a period of time at your poster discussing your project informally with your peers and other members of the NIH community. We also encourage the broader IRP community to support the interns and see and hear some great science.

Wednesday, September 6, 2017, 2:00 pm to 3:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

Join us for the 14th Annual Jeffrey M. Trent Lecture. The 2017 Trent Lecture is titled “Bringing Genomics to the Pediatric Oncology Clinic: Diagnosis, Treatment Selection and Rational Clinical Trial Design” by Katherine Janeway, M.D., Senior Attending Physician in Pediatric Hematology-Oncology and Director of the Solid Tumor Program at Dana-Farber Cancer Institute and Boston Children’s Hospital, as well as an Assistant Professor of Pediatrics at Harvard Medical School.

From the speaker: “The focus of my research is the genomics of pediatric solid tumors including expanding the benefits of the precision cancer medicine approach to children with these cancers and a poor prognosis. In addition, I perform clinical trials of new therapies for pediatric sarcomas. My prior work has defined the genomic underpinnings of osteosarcoma and gastrointestinal stromal tumor, determined that non-standard personalized medicine tests are commonly marketed to cancer patients as being beneficial, established that a multi-institutional precision medicine study is feasible and demonstrated that a significant proportion of children with difficult to treat childhood solid tumors have genomic results with potential clinical benefit. I am the lead pediatric investigator for a comprehensive somatic genotyping study, profile, which has enrolled and sequenced tumor from over 400 pediatric patients. In terms of clinical trials for sarcoma, I am Vice Chair of the Bone Tumor Committee of the Children’s Oncology Group (COG), the principal North American pediatric oncology clinical trials consortium. I am the Study Chair of COG protocol ‘AOST1321, a phase II study of Denosumab in Recurrent Osteosarcoma’ and the institutional PI of 5 phase II, phase III and biology protocols for bone sarcomas and GIST.”

Wednesday, September 27, 2017 to Thursday, September 28, 2017

Natcher Conference Center (Bldg. 45)

Join us for the 2017 NHLBI Cardiovascular Regenerative Medicine Symposium. The event will bring together experts in stem cell biology, cardiovascular development, translational cardiovascular stem cell biology, endogenous heart regeneration and new technologies and models. The emphasis will again be on recent discoveries and trends. We will examine the challenges and critical questions that require answers as the field moves forward to clinical applications. The Symposium’s goals are to help the science and field move forward, to find consensus regarding the translation of stem cell biology and research into a clinical setting, and to inspire participants in their own work. Topic areas are: Stem Cell Biology; Cardiovascular Development; Translational Cardiovascluar Stem Cell Biology; Endogenous Heart Regeneration; and New Technologies and Models. Register online.

Wednesday, September 27, 2017, 3:00 pm to 4:00 pm (reception to follow)

Masur Auditorium, NIH Clinical Center (Bldg. 10)

The first WALS lecture of the 2017–2018 season scheduled so far is a higher-profile Director’s lecture (one of three next season) by Roderick MacKinnon, M.D., of The Rockefeller University. Dr. MacKinnon won the Nobel Prize in Chemistry with Peter Agre in 2003 for his work on the structure and operation of ion channels. 

From the speaker: “Ion channels catalyze the diffusion of inorganic ions down their electrochemical gradients across cell membranes. Because the ionic movements are passive, ion channels would seem to be extraordinarily simple physical systems, yet they are responsible for electrical signaling in living cells. Among their many functions, ion channels control the pace of the heart, regulate the secretion of hormones into the bloodstream, and generate the electrical impulses underlying information transfer in the nervous system. My research is aimed at understanding the physical and chemical principles underlying ion channel function.”

The NIH Director’s Wednesday Afternoon Lecture Series, colloquially known as WALS, is the highest-profile lecture program at the NIH. Lectures occur on most Wednesdays from September through June from 3:00 to 4:00 p.m. in Masur Auditorium, Building 10 on the NIH Bethesda campus.